LifeProNow

MAY 4, 2023

The agency released a new draft guidance that provides recommendations for sponsors, investigators and other stakeholders regarding the implementation of DCTs to advance medical product development and research.

Packaging 130

Packaging 130

European Pharmaceutical Review

MARCH 5, 2024

International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. Innovative startups and smaller companies show great interest in the fair, which has established itself as a springboard for new developments and products. AI is also discussed in imaging and spectroscopy.

Labelling 90

Labelling 90

Pharmaceutical Technology

MARCH 17, 2023

The Lung Cancer Research Foundation (LCRF) has announced a new research partnership with Daiichi Sankyo and AstraZeneca. This collaboration is intended to fund up to three research grants that are focused on antibody-drug conjugates (ADCs) for improving the outcomes for lung cancer patients.

98

98

Express Pharma

SEPTEMBER 14, 2023

The invitation-only event, Sartorius Science Summit, will feature the latest technologies and advancements in the field and networking opportunities to the scientist and researchers community in the life science industry. ‘We, The post Sartorius to host scientific symposium in Hyderabad appeared first on Express Pharma.

Drug Development 52

Drug Development 52

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. They intend to develop vaccines that provide lasting immune responses compared to existing vaccines.

Vaccines 98

Vaccines Immunity Immunization 98

Express Pharma

FEBRUARY 8, 2024

These prestigious awards, organized by IMAPAC, recognize organizations and technologies that contribute to vaccine research and development (R&D) and biologics manufacturing excellence in developing economies, particularly India. The focus is on enhanced speed, reduced cost, and superior quality.

Research Laboratories 90

Research Laboratories Vaccines 90

Pharmaceutical Technology

JANUARY 17, 2023

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development. Free Whitepaper.

Hospitals 110

Hospitals Chemotherapy Communication Immunity 110

pharmaphorum

JANUARY 6, 2023

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients. Excited to share Med-PaLM, a large language model aligned to the medical domain to generate safe and helpful answers.

136

136

Pharmaceutical Technology

MAY 10, 2023

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. According to the US government, Gilead had repeatedly refused to license patents related to PrEP research undertaken by the Department of Health and Human Services’ (HHS) Centers for Disease Control and Prevention (CDC).

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

APRIL 14, 2023

Twist Bioscience has introduced Twist T-cell receptor (TCR) and Twist chimeric antigen receptor (CAR) libraries to facilitate the development of cell therapies. Researchers will now be able to speed up the creation of tailor-made libraries that can help in identifying and developing new cell therapies.

Drug Development 98

Drug Development 98

Pharmaceutical Technology

MARCH 29, 2023

Regeneron Pharmaceuticals has collaborated with Sonoma Biotherapeutics to discover, develop and commercialise new regulatory T cell (Treg) therapies for autoimmune diseases. The two companies will together research and develop T cell therapies for Crohn’s disease and ulcerative colitis, as well as two other undisclosed indications.

98

98

Pharmaceutical Technology

FEBRUARY 16, 2023

The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. Under the deal, MD Anderson and Xilis aim to advance the development of drug and discovery projects using the MOS technology.

Drug Development 96

Drug Development Communication 96

Pharmaceutical Technology

DECEMBER 5, 2022

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. The hub will connect Queensland scientists with the teams at Sanofi’s mRNA Centre of Excellence in the US and France, putting them at the front of international vaccine development and biomedical research.

Vaccines 98

Vaccines Communication Immunity Immunization 98

The Digital Apothecary

DECEMBER 24, 2023

With that being the case, I would say the following stand out for some of the major outcomes associated with these projects and endeavors: APhA AI Policy Development: I was invited to serve on the advisory panel regarding the utilization of AI for the profession, and I spent a weekend alongside other pharmacists in DC discussing policy development.

130

130

European Pharmaceutical Review

OCTOBER 13, 2022

The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide. To solve this problem, the team at MIT developed a multivitamin-sized capsule that tunnels through mucus.

137

137

Pharmaceutical Technology

APRIL 14, 2023

Ginkgo Bioworks (Ginkgo) and the Wisconsin Alumni Research Foundation (WARF) have collaborated to discover next-generation GD2 CAR T-cell therapies to treat solid tumours. Ginkgo will partner with researchers from Wisconsin-Madison to discover new and improved GD2 CAR designs with improved persistence, fitness and proliferation.

105

105

Putting Patients First Blog

OCTOBER 17, 2023

While research behind obesity intervention have, for the past few decades, circumnavigated topics like diet and workout programs, modern medicine has proven that medical interventions, in conjunction with diet and exercise, can drastically aid in the treatment of obesity. Developed with support from Novo Nordisk.

59

59

European Pharmaceutical Review

AUGUST 22, 2023

According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. Theragenix aims to develop the world’s first dry powder gene therapy formulation for bone graft augmentation.

Vaccines 90

Vaccines Packaging 90

Express Pharma

JUNE 29, 2023

Our partnership with Princeton University seeks to enable powerful research in biochemical and advanced materials engineering. We believe our research collaborations will advance science, as well as offer new opportunities to our faculty and students.”

Drug Development 52

Drug Development 52

Pharmaceutical Technology

OCTOBER 25, 2022

Ast ellas Pharma has announced plans to make a strategic investment to back the development of Taysha Gene Therapies’ adeno-associated virus (AAV) development programmes for Rett syndrome and giant axonal neuropathy (GAN). This would allow the companies to boost the development of new therapy options for Rett syndrome and GAN patients.

105

105

Pharmaceutical Technology

JUNE 19, 2023

The pharma company will in-license a small number of gene therapy products and offer research grants to advance them through pre-clinical development. Topic sponsors are not involved in the creation of editorial content. Laurus Labs will be responsible for launching these products in India and emerging markets.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore.

Vaccines 52

Vaccines 52

FDA Law Blog: Biosimilars

MARCH 6, 2024

The American Conference Institute (“ACI”) will be hosting a series of go-to forums on critical topics including novel therapeutics, cosmetics/personal care products and Paragraph IV disputes. He’ll be speaking on “Bridging the Gap: From Pre-Commercialization Research to Regulatory Approval for Novel Therapeutics and Regenerative Medicines.”

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Drug Development Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies.

Vaccines 98

Vaccines Immunity Immunization Communication 98

Pharmaceutical Technology

APRIL 21, 2023

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

98

98

European Pharmaceutical Review

JUNE 26, 2023

There were 61 RWD research opportunities identified, 30 studies initiated and 27 completed in this period. Use of RWE is less established in earlier stages of medicines development, the EMA stated. Real-world evidence (RWE) from these studies can complement evidence from other sources including clinical trials.

Medical Records 80

Medical Records Clinic Management 80

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. Topic sponsors are not involved in the creation of editorial content. This will improve accessibility to services for AAV-mediated gene therapy programmes.

Drug Development 102

Drug Development 102

European Pharmaceutical Review

JULY 13, 2023

3 With established drug development pathways, we are accustomed to a rigid structure of translation from bench to bedside. While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. Just an excuse?

Compounding 88

Compounding Drug Development Clinical Pharmacology Documentation 88

Putting Patients First Blog

FEBRUARY 29, 2024

Department of Defense Congressionally Directed Medical Research Programs February 29, 2024 By: Allen Pinn, Coordinator, Policy Introduction The Department of Defense’s (DOD) Congressionally Directed Medical Research Programs (CDMRP) were established in 1992 by Congress in response to a desire for more investment in biomedical research.

52

52

Pharmaceutical Technology

APRIL 20, 2023

Situated at the hub of the country’s northeastern pharmaceutical corridor, the new facility is staffed by research, application and formulation specialists. It also aims to contribute to the pharmaceutical sector by facilitating cross-industry partnerships and research-based product development.

Dosage 52

Dosage 52

Pharmaceutical Technology

MAY 30, 2023

As part of an exclusive licensing agreement, Amplo Biotechnology secured access to AAV-ColQ data developed by Professor Kinji Ohno’s laboratory at Nagoya University, which forms the basis of the therapy. It also develops adeno-associate virus-based gene therapies for neuromuscular junction disorders.

97

97

Pharmaceutical Technology

APRIL 17, 2023

The company will provide regulatory advice to Incannex, and manage clinical trials to develop CannQuit and ReneCann products to treat addiction and immune-disordered skin diseases. The company will help in managing the clinical trials of the products once the regulators provide approvals for the proposed research and development programmes.

Immunity 52

Immunity Immunization Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 16, 2021

UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed second-round financing that will help fund clinical development of its psilocybin-based therapies. The post Beckley Psytech raises $80m for psychedelic meds development appeared first on.

Compounding 135

Compounding 135

Pharmaceutical Technology

OCTOBER 19, 2022

Akouos focuses on developing adeno-associated viral gene therapies to treat inner ear conditions, including sensorineural hearing loss. Topic sponsors are not involved in the creation of editorial content. The post Lilly agrees to acquire gene therapy developer Akouos for $610m appeared first on Pharmaceutical Technology.

119

119

Pharmaceutical Technology

SEPTEMBER 29, 2022

Scribe Therapeutics and Sanofi have signed a strategic partnership to expedite the development of breakthrough clustered regularly interspaced short palindromic repeats (CRISPR)-based cell therapies for cancer. Scribe is also entitled to receive potential payments worth over $1bn on meeting development and commercial milestones.

52

52

pharmaphorum

JANUARY 18, 2022

Envision Pharma’s scientific solutions division lead Rebecca Goldstein, discusses this topic and other developments that cancer patients and their loved ones should be paying attention to. Developments to watch. Cancer patients and their loved ones can easily get overwhelmed by the sheer number of choices available.

98

98

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. Personalised medicines will also be developed at the centre.

Communication 105

Communication 105